Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 109 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Multiple Myeloma Refractory to Lenalidomide: A Systematic Literature Review of Trials and Real-World Evidence
Monique A. Hartley-Brown, Katja Weisel,Jacopo Bitetti, John A. Carter, Simon McNamara, Molly Purser,Antonio Palumbo,Paul G. Richardson
BRITISH JOURNAL OF HAEMATOLOGY (2024)
Cited0Views0WOSBibtex
0
0
P-405 EXCALIBER-RRMM: A Phase 3, Two-Stage Trial of Iberdomide, Daratumumab, Dexamethasone (iberdd) Versus Daratumumab, Bortezomib, Dexamethasone (dvd) in Patients with Relapsed/Refractory Multiple Myeloma
Sagar Lonial, Hang Quach,Meletios Dimopoulos, Paula Rodríguez-Otero,Jesus Berdeja,Paul Richardson, Margee Kyada, Sakiko Kuroda,Shuyu Chu, Paulo Maciag, Patricia C. Abad,Juliane Morando, Niels van de Donk
Clinical Lymphoma Myeloma and Leukemia (2024): S268
Cited0Views0Bibtex
0
0
OA-29 Mezigdomide (MEZI), Tazemetostat (TAZ), and Dexamethasone (DEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results from the CA057-003 Trial
Luciano Costa,Rakesh Popat, David Siegel,Fredrik Schjesvold,Saad Usmani,Nizar J. Bahlis,Albert Oriol,Michael Chu, Syed Abbas Ali, Karthik Ramasamy,Monique Hartley-Brown, Joaquín Martínez-Lopez, Allison Gaudy, Antonina Kurtova, Wen Zhang,Rafael Sarmiento, August Dietrich,Jessica Katz,Michael Pourdehnad,Paul Richardson
Clinical Lymphoma Myeloma and Leukemia (2024): S19
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 105

#Citation: 2830

H-Index: 21

G-Index: 53

Sociability: 7

Diversity: 0

Activity: 1

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn